The FDA has approved Aprocitentan for the treatment of resistant hypertension in adults. This medication is intended for patients who have not been able to adequately control their blood pressure with existing antihypertensive therapies. Aprocitentan functions by targeting endothelin receptors, which are involved in blood vessel constriction, thereby helping to lower blood pressure when used in conjunction with other treatments.